ArticleMalaria journal2023

The malaria blood stage antigen PfCyRPA formulated with the TLR-4 agonist adjuvant GLA-SE elicits parasite growth inhibitory antibodies in experimental animals.

Marco Tamborrini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.